triazolam has been researched along with Chronic Disease in 11 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a parallel-group, placebo-controlled, polysomnographic study with randomization, the possible occurrence of rebound insomnia was evaluated in 24 patients suffering from moderate to severe chronic insomnia and receiving either triazolam 0." | 9.07 | Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients. ( Attali, P; de la Giclais, B; Monti, D; Monti, JM; Morselli, PL; Zipfel, A, 1994) |
| "In a parallel-group, placebo-controlled, polysomnographic study with randomization, the possible occurrence of rebound insomnia was evaluated in 24 patients suffering from moderate to severe chronic insomnia and receiving either triazolam 0." | 5.07 | Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients. ( Attali, P; de la Giclais, B; Monti, D; Monti, JM; Morselli, PL; Zipfel, A, 1994) |
| "Twelve volunteers with a complaint of chronic insomnia participated in a placebo-controlled, double-blind, crossover study of the effects of buspirone t." | 5.05 | Buspirone: an anxiolytic without sedative effect. ( Bliwise, NG; Cohen, SA; Dement, WC; Seidel, WF, 1985) |
| "Patients with chronic orofacial pain often report disturbances in sleep, leading to the hypothesis that nocturnal motor hyperactivity of the muscles of mastication may contribute to the nociceptive process." | 2.69 | Triazolam improves sleep but fails to alter pain in TMD patients. ( DeNucci, DJ; Dionne, RA; Sobiski, C, 1998) |
| "Triazolam was more effective than zolpidem 5 mg but not zolpidem 10 mg, and there was no significant difference between zolpidem 5 mg and zolpidem 10 mg." | 2.67 | Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. ( George, CF; Kryger, MH; Millar, TW; Pouliot, Z; Steens, RD, 1993) |
| "Triazolam (0." | 2.64 | Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs. ( Bowen, AJ, 1978) |
| "In general, chronic insomniacs showed all degrees of daytime alertness regardless of nocturnal sleep parameters." | 2.37 | Issues in the diagnosis and treatment of insomnia. ( Carskadon, M; Dement, W; Seidel, W, 1984) |
| "The diagnosis and treatment of insomnia is a major clinical issue." | 2.36 | Rational basis for the use of sleeping pills. ( Dement, WC, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dement, WC | 2 |
| Dement, W | 1 |
| Seidel, W | 1 |
| Carskadon, M | 1 |
| Monti, JM | 1 |
| Attali, P | 1 |
| Monti, D | 1 |
| Zipfel, A | 1 |
| de la Giclais, B | 1 |
| Morselli, PL | 1 |
| Steens, RD | 1 |
| Pouliot, Z | 1 |
| Millar, TW | 1 |
| Kryger, MH | 1 |
| George, CF | 1 |
| Muzychenko, AP | 1 |
| Prokudin, VN | 1 |
| Bogdan, AN | 1 |
| DeNucci, DJ | 1 |
| Sobiski, C | 1 |
| Dionne, RA | 1 |
| Bunney, WE | 1 |
| Azarnoff, DL | 1 |
| Brown, BW | 1 |
| Cancro, R | 1 |
| Gibbons, RD | 1 |
| Gillin, JC | 1 |
| Hullett, S | 1 |
| Killam, KF | 1 |
| Kupfer, DJ | 1 |
| Krystal, JH | 1 |
| Stolley, PD | 1 |
| French, GS | 1 |
| Pope, AM | 1 |
| Bowen, AJ | 1 |
| Walsh, JK | 1 |
| Mahowald, MW | 1 |
| Seidel, WF | 1 |
| Cohen, SA | 1 |
| Bliwise, NG | 1 |
| Mamelak, M | 1 |
| Csima, A | 1 |
| Price, V | 1 |
2 reviews available for triazolam and Chronic Disease
| Article | Year |
|---|---|
Rational basis for the use of sleeping pills.
Topics: Anxiety; Chronic Disease; Flurazepam; Humans; Hypnotics and Sedatives; Kinetics; Sleep; Sleep Initia | 1983 |
Issues in the diagnosis and treatment of insomnia.
Topics: Chronic Disease; Flurazepam; Humans; Hypnotics and Sedatives; Psychomotor Performance; Respiration; | 1984 |
6 trials available for triazolam and Chronic Disease
| Article | Year |
|---|---|
Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Topics: Adult; Aged; Anxiety; Chronic Disease; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; | 1994 |
Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease.
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Lung Dis | 1993 |
[Halcion (triazolam) in the treatment of insomnia].
Topics: Adult; Chronic Disease; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Sleep Initiation | 1997 |
Triazolam improves sleep but fails to alter pain in TMD patients.
Topics: Adult; Chronic Disease; Cross-Over Studies; Double-Blind Method; Electromyography; Facial Pain; GABA | 1998 |
Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs.
Topics: Adult; Anti-Anxiety Agents; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; | 1978 |
Buspirone: an anxiolytic without sedative effect.
Topics: Adult; Anti-Anxiety Agents; Buspirone; Chronic Disease; Clinical Trials as Topic; Double-Blind Metho | 1985 |
3 other studies available for triazolam and Chronic Disease
| Article | Year |
|---|---|
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion.
Topics: Adverse Drug Reaction Reporting Systems; Chronic Disease; Drug Approval; Drug Evaluation; Evaluation | 1999 |
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepa | 1991 |
Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Drug Tolerance; Female; Humans; Male; | 1985 |